<PAGE> 1
U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
[ ] Form 10-K [ ] Form 11-K [X] Form 10-Q [ ] Form N-SAR
For Period Ended: March 31, 1997
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
Read Attached Instruction Sheet Before Preparing Form. Please Print or
Type.
Nothing in this Form shall be construed to imply that the Commission has
verified any information contained herein.
- -------------------------------------------------------------------------------
If the notification relates to a portion of the filing checked above,
identify the Item(s) to which the notification relates:
-----------------------------------------------------------------------
- -------------------------------------------------------------------------------
PART I - REGISTRANT INFORMATION
- -------------------------------------------------------------------------------
Full Name of Registrant: Viragen (Europe) Ltd.
Former Name if Applicable: Not Applicable
2343 West 76th Street
- -------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
Hialeah, Florida 33016
- -------------------------------------------------------------------------------
City, State and Zip Code
- -------------------------------------------------------------------------------
Part II - Rules 12b-25(b) and (c)
- -------------------------------------------------------------------------------
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b) [Paragraph 23,047],
the following should be completed. (Check box, if appropriate)
<PAGE> 2
[X] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[X] (b) The subject annual report, semi-annual report, transition report on
Form 10-K, Form 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or
before the fifteenth calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q, or portion thereof
will be filed on or before the fifth calendar day following the prescribed due
date; and [Amended in Release No. 34-26589 (Paragraph 72,435), effective April
12, 1989, 54 F.R. 10306.]
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
- -------------------------------------------------------------------------------
Part III - NARRATIVE
- -------------------------------------------------------------------------------
State below in reasonable detail the reasons why Form 10-K, 20-F, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof could not be filed within
the prescribed time period. [Amended in Release No. 34-26589 (Paragraph 72,435),
effective April 12, 1989, 54 F.R. 10306.]
THE FORM 10-Q COULD NOT BE FILED WITHIN THE PRESCRIBED TIME PERIOD
BECAUSE OF ADDITIONAL TIME REQUIRED BY THE REGISTRANT'S FINANCIAL
MANAGEMENT ATTRIBUTABLE TO THE IMPLEMENTATION OF NEW ACCOUNTING
HARDWARE AND SOFTWARE.
- -------------------------------------------------------------------------------
Part IV - OTHER INFORMATION
- -------------------------------------------------------------------------------
(1) Name and telephone number of person to contact in regard to this
notification:
Dennis W. Healey (305) 577-6000
---------------------------- ------------- ----------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 of Section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s). [X] Yes [ ] No
2
<PAGE> 3
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[ ] Yes [X] No
If so, attach an explanation of the anticipated change, both
narratively and quantitatively, and, if appropriate, state the reasons why a
reasonable estimate of the results cannot be made.
Viragen (Europe) Ltd.
- ------------------------------------------------------------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
VIRAGEN (EUROPE) LTD.
Date: May 15, 1997 By: /s/ Dennis W. Healey
---------------------------
Dennis W. Healey
Principal Financial Officer
3
